XML 42 R31.htm IDEA: XBRL DOCUMENT v3.25.1
(Loss) Earnings Per Share (Tables)
3 Months Ended
Mar. 31, 2025
Earnings Per Share [Abstract]  
Schedule of computations of basic and diluted loss per share

The following table presents computations of basic and diluted (loss) earnings per share for Holdings:

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2025

 

 

2024

 

Numerator:

 

 

 

 

 

 

Net (loss) income attributable to Cinemark Holdings, Inc.

 

$

(38.9

)

 

$

24.8

 

Loss (income) allocated to participating share-based awards (1)

 

 

0.4

 

 

 

(0.4

)

Basic net (loss) income attributable to common stockholders

 

$

(38.5

)

 

$

24.4

 

Add: Interest expense on convertible notes, net of tax (3)

 

 

 

 

 

4.8

 

Diluted net (loss) income attributable to common stockholders

 

$

(38.5

)

 

$

29.2

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

Basic weighted average shares outstanding

 

 

119.4

 

 

 

119.5

 

Common equivalent shares for performance and restricted stock units (2)

 

 

 

 

 

0.9

 

Common equivalent shares for convertible notes (3)

 

 

 

 

 

32.0

 

Common equivalent shares for warrants (4)

 

 

 

 

 

 

Diluted weighted average shares outstanding

 

 

119.4

 

 

 

152.4

 

 

 

 

 

 

 

 

Basic (loss) earnings per share attributable to common stockholders

 

$

(0.32

)

 

$

0.20

 

Diluted (loss) earnings per share attributable to common stockholders

 

$

(0.32

)

 

$

0.19

 

(1)
For the three months ended March 31, 2025 and 2024, a weighted average of approximately 1.30 shares and 2.00 shares of restricted stock, respectively, were considered participating securities.
(2)
For the three months ended March 31, 2025, approximately 2.10 common equivalent shares for performance and restricted stock units were excluded because they were anti-dilutive.
(3)
For the three months ended March 31, 2025, diluted loss per share excludes the conversion of the 4.50% Convertible Senior Notes into 32.0 shares of common stock as they would be anti-dilutive. See further discussion below.
(4)
For the three months ended March 31, 2025 and 2024, diluted (loss) earnings per share excludes the warrants, as they would be anti-dilutive.